Literature DB >> 26077260

Effective inhibition of HIV-1 production by short hairpin RNAs and small interfering RNAs targeting a highly conserved site in HIV-1 Gag RNA is optimized by evaluating alternative length formats.

Robert J Scarborough1, Kelsey L Adams1, Aïcha Daher2, Anne Gatignol3.   

Abstract

We have previously identified a target site in HIV-1 RNA that was particularly accessible to a ribozyme and a short hairpin RNA (shRNA). To design small interfering RNAs (siRNAs) targeting this site, we evaluated the effects of siRNAs with different lengths on HIV-1 production. The potency and efficacy of these siRNAs were dependent on the length of their intended sense strand with trends for symmetrical and asymmetrical formats that were similar. Although a typical canonical format with a 21-nucleotide (nt) sense strand was effective at inhibiting HIV-1 production, Dicer substrate siRNAs (dsiRNAs) with the longest lengths (27 to 29 nucleotides) were the most effective. Induction of double-stranded RNA immune responses and effects on cell viability were not detected in cells transfected with different siRNAs, suggesting that the differences observed were not related to indirect effects on HIV-1 production. For the corresponding shRNA designs, a different trend in potency and efficacy against HIV-1 production was observed, with the most effective shRNAs having stem lengths from 20 to 27 bp. Our results highlight the importance of evaluating different designs to identify the best siRNA and shRNA formats for any particular target site and provide a set of highly effective molecules for further development as drug and gene therapies for HIV-1 infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26077260      PMCID: PMC4538472          DOI: 10.1128/AAC.00949-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

1.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

2.  Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.

Authors:  Jiehua Zhou; C Preston Neff; Xiaoxuan Liu; Jane Zhang; Haitang Li; David D Smith; Piotr Swiderski; Tawfik Aboellail; Yuanyu Huang; Quan Du; Zicai Liang; Ling Peng; Ramesh Akkina; John J Rossi
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

3.  Functional characterization of the SOFA delta ribozyme.

Authors:  Lucien Junior Bergeron; Cédric Reymond; Jean-Pierre Perreault
Journal:  RNA       Date:  2005-10-26       Impact factor: 4.942

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.

Authors:  David L DiGiusto; Amrita Krishnan; Lijing Li; Haitang Li; Shirley Li; Anitha Rao; Shu Mi; Priscilla Yam; Sherri Stinson; Michael Kalos; Joseph Alvarnas; Simon F Lacey; Jiing-Kuan Yee; Mingjie Li; Larry Couture; David Hsu; Stephen J Forman; John J Rossi; John A Zaia
Journal:  Sci Transl Med       Date:  2010-06-16       Impact factor: 17.956

6.  T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Authors:  Priti Kumar; Hong-Seok Ban; Sang-Soo Kim; Haoquan Wu; Todd Pearson; Dale L Greiner; Amale Laouar; Jiahong Yao; Viraga Haridas; Katsuyoshi Habiro; Yong-Guang Yang; Ji-Hoon Jeong; Kuen-Yong Lee; Yong-Hee Kim; Sung Wan Kim; Matthias Peipp; Georg H Fey; N Manjunath; Leonard D Shultz; Sang-Kyung Lee; Premlata Shankar
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

7.  The effects of stem length and core placement on shRNA activity.

Authors:  Glen J McIntyre; Yi-Hsin Yu; Mehnaaz Lomas; Gregory C Fanning
Journal:  BMC Mol Biol       Date:  2011-08-08       Impact factor: 2.946

8.  Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.

Authors:  Masayuki Sano; Malgorzata Sierant; Makoto Miyagishi; Mahito Nakanishi; Yasuomi Takagi; Shizuyo Sutou
Journal:  Nucleic Acids Res       Date:  2008-09-09       Impact factor: 16.971

9.  Optimal design and validation of antiviral siRNA for targeting HIV-1.

Authors:  Yuki Naito; Kyoko Nohtomi; Toshinari Onogi; Rie Uenishi; Kumiko Ui-Tei; Kaoru Saigo; Yutaka Takebe
Journal:  Retrovirology       Date:  2007-11-08       Impact factor: 4.602

10.  A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA.

Authors:  Robert J Scarborough; Michel V Lévesque; Etienne Boudrias-Dalle; Ian C Chute; Sylvanne M Daniels; Rodney J Ouellette; Jean-Pierre Perreault; Anne Gatignol
Journal:  Mol Ther Nucleic Acids       Date:  2014-07-29       Impact factor: 10.183

View more
  6 in total

1.  Efficient inhibition of human immunodeficiency virus replication using novel modified microRNA-30a targeting 3'-untranslated region transcripts.

Authors:  Ahmad Nejati; Shohreh Shahmahmoodi; Ehsan Arefian; Zabihollah Shoja; Sayed-Mahdi Marashi; Hamideh Tabatabaie; Yaghoub Mollaei-Kandelous; Masoud Soleimani; Rakhshandeh Nategh
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

2.  Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy.

Authors:  Robert J Scarborough; Kelsey L Adams; Olivier Del Corpo; Aïcha Daher; Anne Gatignol
Journal:  J Vis Exp       Date:  2016-09-05       Impact factor: 1.355

Review 3.  Cell and gene therapy strategies to eradicate HIV reservoirs.

Authors:  Chelsea Spragg; Harshana De Silva Feelixge; Keith R Jerome
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

Review 4.  RNA Interference Therapies for an HIV-1 Functional Cure.

Authors:  Robert J Scarborough; Anne Gatignol
Journal:  Viruses       Date:  2017-12-27       Impact factor: 5.048

Review 5.  Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.

Authors:  Aurélie Delannoy; Mikaël Poirier; Brendan Bell
Journal:  Viruses       Date:  2019-03-18       Impact factor: 5.048

6.  A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy.

Authors:  Olivier Del Corpo; Ryan P Goguen; Camille M G Malard; Aïcha Daher; Susan Colby-Germinario; Robert J Scarborough; Anne Gatignol
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-18       Impact factor: 8.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.